Growth Hormone

Altus and Althea pair up

Altus and Althea pair up

By Gregory Roumeliotis

Biopharmaceutical firm Altus has asked contract manufacturer Althea
to produce Phase III quantities of a crystallised formulation of
human growth hormone (hGH) which can be administered subcutaneously
weekly instead of daily.

The perils of whistleblowing

In-PharmaTechnologist special feature

The perils of whistleblowing

By Kirsty Barnes

The firing of Dr Peter Rost by Pfizer highlights the position that
employees can be faced with if they take a stand on what they
believe to be illegal activity in the companies they work for.

Spotlight

Follow us

Webinars

Featured Suppliers

All